Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference46 articles.
1. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes;Perry;Nature,2014
2. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015
3. Challenges and management of liver cirrhosis: practical issues in the therapy of patients with cirrhosis due to NAFLD and NASH;Traussnigg;Dig. Dis.,2015
4. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015
5. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies;Musso;Drug Discov.,2016
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications;Acta Pharmaceutica Sinica B;2024-08
2. The discovery of a new potent FXR agonist based on natural product screening;Bioorganic Chemistry;2024-02
3. Natural Products in the Modulation of Farnesoid X Receptor Against Nonalcoholic Fatty Liver Disease;The American Journal of Chinese Medicine;2024-01
4. Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development;Pharmacological Research;2023-10
5. Cycloastragenol inhibits adipogenesis and fat accumulation in vitro and in vivo through activating Hedgehog signaling;Food Science and Biotechnology;2023-09-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3